News from genomedx A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Dec 22, 2014, 08:00 ET

Study Published in European Urology Shows that the Decipher Prostate Cancer Classifier is Predictive of Rapid Metastasis in High-Risk Men who have had Prostate Surgery

GenomeDx Biosciences today announced that a new study showed that the Decipher Prostate Cancer Classifier, a genomic test for prostate cancer, was...

Nov 11, 2014, 08:00 ET

GenomeDx and Mayo Clinic Enter Agreement to Conduct Validation Study of Decipher® Prostate Cancer Test in Patients Receiving Biopsy Prior to Treatment

 GenomeDx Biosciences today announced that the company has expanded its research agreement with Mayo Clinic to initiate a validation study to...

Oct 16, 2014, 22:52 ET

Centers for Medicare and Medicaid Services Publishes Draft Coverage Decision to Reimburse the Decipher® Test for Intermediate & High Risk Prostate Cancer

GenomeDx Biosciences today announced that a draft local coverage determination (LCD) for its Decipher® Prostate Cancer Classifier has been...

Sep 25, 2014, 08:00 ET

GenomeDx Adds a National PPO to Make Available Decipher® Prostate Cancer Test

 GenomeDx Biosciences today announced that it has entered into a contractual agreement with MultiPlan, Inc. for diagnostic laboratory testing....

Sep 17, 2014, 18:00 ET

GenomeDx Announces Presentation of Positive Results From New Validation Study for Decipher® at the Annual Meeting of the American Society for Radiation Oncology (ASTRO) in San Francisco

 GenomeDx Biosciences today announced that data featured in an oral presentation at the 56th Annual Meeting of the American Society for...

Sep 15, 2014, 20:30 ET

Two New Studies Show Decipher Genomic Prostate Cancer Test Charts Best Course of Treatment and Influences Patient Outcomes

GenomeDx Biosciences today announced data from two new studies presented at the American Society for Radiation Oncology (ASTRO) Annual Meeting...

Jun 16, 2014, 08:00 ET

GenomeDx Expands Insurance Coverage for Decipher® Prostate Cancer Test Through Contract with Prime Health Services

 GenomeDx Biosciences today announced that it has entered into a contractual agreement as a participating provider with Prime Health Services...

May 20, 2014, 15:30 ET

Studies Show that GenomeDx Biosciences' Decipher® Test is a Better Predictor of Metastatic Prostate Cancer than Existing Tools

GenomeDx Biosciences today announced the presentation of data showing that its Decipher® Prostate Cancer Classifier, a genomic test capable...

May 16, 2014, 08:00 ET

GenomeDx Biosciences Launches Decipher® Portal Professional, a Revolutionary Mobile App for Physicians Caring for Prostate Cancer Patients

 GenomeDx Biosciences today announced the launch of the Decipher® Portal Professional, a mobile app designed for iPad tablets that allows...

May 14, 2014, 08:00 ET

Peer Review Studies Find Decipher® Genomic Test Significantly Changes Postoperative Treatment Recommendations for Prostate Cancer Patients and Increases Confidence in Treatment Decisions

GenomeDx Biosciences today announced data from two new clinical utility studies demonstrating that Decipher® Prostate Cancer Classifier...

May 08, 2014, 08:00 ET

Decipher® Genomic Prostate Cancer Test to Be Featured in Multiple Presentations and Events at Upcoming AUA Annual Meeting

GenomeDx Biosciences announced today that the company's Decipher® Prostate Cancer Classifier will be featured in multiple sessions during the...

Apr 11, 2014, 08:00 ET

GenomeDx Biosciences Announces Data on Genomic Tests for Prostate and Bladder Cancer to be Presented at EAU Annual Meeting

 GenomeDx Biosciences announced today that two study abstracts for the company's genomic tests for prostate and bladder cancers have been...

Mar 04, 2014, 08:00 ET

GenomeDx Biosciences to Present at 2014 Cowen and Company Healthcare Conference

GenomeDx Biosciences announced that it will present today at the 34th Annual Cowen and Company Healthcare Conference at 4:30 p.m. ET in Boston,...

Feb 03, 2014, 08:00 ET

FEDMED to Provide Insurance Coverage for Decipher® Prostate Cancer Test

 GenomeDx Biosciences today announced that it has entered into a contractual agreement to provide its Decipher® prostate cancer test to...

Jan 30, 2014, 08:00 ET

GenomeDx Biosciences' Decipher® Test Predicts Radiation Therapy Failure and Identifies Candidates for Early Radiation Therapy Following Prostate Surgery

 GenomeDx Biosciences today announced new data demonstrating that its Decipher® Prostate Cancer Classifier, a genomic test capable of...

Nov 20, 2013, 08:00 ET

GenomeDx Biosciences Inc. Secures Insurance Coverage for Decipher® Prostate Cancer Classifier

 GenomeDx Biosciences today announced that it has entered into contractual agreements for diagnostic laboratory testing as a participating...

Sep 30, 2013, 08:00 ET

GenomeDx Biosciences Closes Series B Financing

 GenomeDx Biosciences Inc, announced today it has closed a Series B financing round led by Merck Global Health Innovation Fund (GHIF) and other...

May 08, 2013, 13:30 ET

Study Shows GenomeDx's Decipher™ Test Effectively Predicts Rapid Metastatic Prostate Cancer

GenomeDx Biosciences today announced that data presented by Johns Hopkins University School of Medicine researchers at the 2013 Annual Meeting for...

May 08, 2013, 11:00 ET

New Study Demonstrates that GenomeDx's Decipher™ Test was Superior to Current Risk Assessment Tools in Predicting Metastatic Prostate Cancer

 GenomeDx Biosciences today announced the presentation of results of an independent validation study demonstrating that Decipher™ was...